Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | es un[a] | producto que contiene clorhexidina y tolnaftato en forma farmacéutica para administración cutánea como únicos ingredientes (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | adopta un rol | rol terapéutico antifúngico | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene base de sustancia de la potencia | Tolnaftate (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Tolnaftate (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene base de sustancia de la potencia | clorhidrato de clorhexidina | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | clorhidrato de clorhexidina | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | es un[a] | producto con tolnaftato | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | antinfeccioso local (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | Tolnaftate (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | agente dermatológico | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | clorhidrato de clorhexidina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | es un[a] | tolnaftato + clorhidrato de clorhexidina (producto) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | antinfeccioso local (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | agente tópico (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | es un[a] | producto con clorhexidina y tolnaftato | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene como ingrediente activo | agente dermatológico | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | forma farmacéutica cutánea Y/O transdérmica (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | polvo medicamentoso (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | Cutaneous powder | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | es un[a] | producto que contiene clorhexidina en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | es un[a] | producto que contiene tolnaftato de sodio en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene valor de numerador de potencia de concentración | 2,5 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene base de sustancia de la potencia | Tolnaftate (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | recuento de bases de ingrediente activo | 2 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Tolnaftate (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | clorhidrato de clorhexidina | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene base de sustancia de la potencia | clorhidrato de clorhexidina | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | tiene valor de numerador de potencia de concentración | 10 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets